Related Experiment Video
Updated: May 11, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy
Habib Safigholi1, Dariush Sardari, Somaye Karimi Jashni
1Department of Radiation Medical Engineering,1 Science and Research Branch, Islamic Azad University, Tehran, Iran. safigholi@gmail.com
Journal of Applied Clinical Medical Physics
|May 9, 2013
Summary
A new analytical method accurately calculates dose perturbations and interseed attenuation in brachytherapy implants, improving treatment planning for 125I and 192Ir seeds.
Area of Science:
- Medical Physics
- Radiation Oncology
- Dosimetry
Background:
- Brachytherapy treatment planning systems (BTPS) use dosimetric parameters measured in water, neglecting heterogeneities in implants.
- Interseed attenuation (ISA) and dose perturbations from multiple seeds are not accounted for in current BTPS.
- Accurate dose calculation in non-homogeneous brachytherapy implants is crucial for effective treatment.
Purpose of the Study:
- To develop a novel analytical method for evaluating dose perturbations (P-value) and interseed attenuation (ISA-value) in multisource brachytherapy implants.
- To validate this method using Monte Carlo (MC) simulations for 125I and 192Ir brachytherapy seeds.
- To provide a faster and easier alternative to full Monte Carlo water simulations for clinical application.
Main Methods:
- Developed an analytical model based on MC-simulated 3D kernels of P-values and ISA data for single seed configurations.
- Arranged single active and dummy seeds at various distances and orientations to simulate multisource implants.
- Validated the model by comparing calculated P-values and ISA-values against full Monte Carlo water simulations (FMCWS).
Main Results:
- The novel analytical model accurately determined total perturbation and ISA values for multisource implants, showing excellent agreement with FMCWS.
- The model demonstrated faster calculations and easier implementation compared to FMCWS for daily clinical use.
- The model showed higher accuracy for 192Ir than 125I due to Compton scattering, with a maximum ISA difference of less than 5% compared to FMCWS.
Conclusions:
- The developed analytical model effectively calculates dose perturbations and interseed attenuation in brachytherapy implants.
- This method can be integrated into brachytherapy planning software to enhance dose calculation accuracy based on TG-43U1.
- The model offers a clinically applicable, efficient, and accurate approach for heterogeneous brachytherapy dosimetry.
More Related Videos
07:31Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:06Three-Compartment Open Model
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
01:20Compartment Models: Two-Compartment Model
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
01:15Two-Compartment Open Model: IV Infusion
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...